Avsnittsbeskrivning
This month’s episode of HAE Speaks provides insight into living with hereditary angioedema (HAE) and treatment with TAKHZYRO® (lanadelumab-flyo), a prescription medicine used to prevent attacks of HAE in people two years of age and older. Join Chaeli Wallace, Takeda’s Senior Manager for Patient Community and Education, as she interviews Nina, a person living with HAE, about her journey from diagnosis to treatment with TAKHZYRO. Thank you to Takeda for sponsoring this episode!
What is TAKHZYRO?
TAKHZYRO (lanadelumab-flyo) is a prescription medicine used to prevent attacks of hereditary…
Webbplats: podcasters.spotify.com

